Related references
Note: Only part of the references are listed.Towards 'off-the-shelf' genetically modified T cells: prolonging functional engraftment in mice by CD8 veto T cells
N. Or-Geva et al.
LEUKEMIA (2018)
Cytotoxic T-lymphocyte therapy for post-transplant lymphoproliferative disorder after solid organ transplantation in children
Fang Kuan Chiou et al.
PEDIATRIC TRANSPLANTATION (2018)
Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease
Rebecca E. Schultze-Florey et al.
FRONTIERS IN IMMUNOLOGY (2018)
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
Ifigeneia Tzannou et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
Ralf U. Trappe et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes
Swati Naik et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells
Manuel Albanese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Post-transplant lymphoproliferative disorders: From epidemiology to pathogenesis-driven treatment
Maria Raffaella Petrara et al.
CANCER LETTERS (2015)
Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): Technical recommendations for the use of Short Tandem Repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Working Group
Jordan R. Clark et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era
C. P. Fox et al.
BONE MARROW TRANSPLANTATION (2014)
Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease
Mark A. Vickers et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients
R. San-Juan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells: Lessons From a Phase I/II Feasibility and Safety Study
Geraldine Gallot et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
Ann M. Leen et al.
BLOOD (2013)
Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?
J. Morscio et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus-Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Jan Styczynski et al.
CLINICAL INFECTIOUS DISEASES (2013)
Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1-Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
Vanya Icheva et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina et al.
BLOOD (2012)
Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease
Michael Uhlin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
Ralf Trappe et al.
LANCET ONCOLOGY (2012)
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2012)
The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders
Denis Glotz et al.
TRANSPLANTATION (2012)
High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts
M. Hoegh-Petersen et al.
BONE MARROW TRANSPLANTATION (2011)
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
Juliet N. Barker et al.
BLOOD (2010)
Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products
Maaike E. Ressing et al.
SEMINARS IN CANCER BIOLOGY (2008)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution
Sylvain Choquet et al.
ANNALS OF HEMATOLOGY (2007)
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation
P. Comoli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Treatment of solid organ transplant recipients with autologolus Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)
Barbara Savoldo et al.
BLOOD (2006)
Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-Specific T cells
P Comoli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy
MA Sherritt et al.
TRANSPLANTATION (2003)
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes
G Koehne et al.
NATURE BIOTECHNOLOGY (2003)
Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma
Q Sun et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
T Haque et al.
LANCET (2002)
Infusion of autologous Epstein-Barr virus (EBV) -: specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication
P Comoli et al.
BLOOD (2002)
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
S Gottschalk et al.
BLOOD (2001)
Share Paper
